ArticleFrontiers in medicine2026
Assessment of oxidative stress-induced cellular damage in preeclamptic females.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Preeclampsia is a hypertensive disorder of pregnancy characterized by the development of hypertension and proteinuria after 20 weeks of gestation. Oxidative stress, arising from an imbalance between reactive oxygen species (ROS) production and antioxidant defenses, has been implicated in the pathogenesis of preeclampsia. Methods: This study aimed to assess oxidative stress-induced cellular damage in preeclamptic females through the evaluation of oxidative stress biomarkers and their association with disease severity. Blood samples were collected from preeclamptic females and normotensive pregnant controls matched for gestational age. Routine biochemical investigations, including serum uric acid and lactate dehydrogenase (LDH) levels, were measured. Results: The results revealed significantly elevated levels of oxidative stress biomarkers in preeclamptic females compared to normotensive controls. Serum LDH levels were significantly increased in preeclampsia, and with the severity of the disease, the levels were higher. Serum LDH levels showed a significant correlation with serum uric acid levels. Furthermore, a positive correlation was observed between oxidative stress parameters and disease severity, as indicated by blood pressure levels, transaminases, and proteinuria. Discussion: These findings underscore the importance of oxidative stress-induced cellular damage in the pathophysiology of preeclampsia and highlight the potential utility of oxidative stress biomarkers as diagnostic and prognostic indicators in this hypertensive disorder of pregnancy. Further research is warranted to elucidate the underlying mechanisms linking oxidative stress to preeclampsia and explore novel therapeutic strategies targeting oxidative stress pathways in the management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.